Cecilia Pita
Ramos Mejia, B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Efficacy and safety of Cladribine as a therapeutic option in multiple sclerosis patients over 50 years of age: A real-world study.
Journal: Journal of the neurological sciences
Published: August 11, 2025
Progression independent of relapse activity (PIRA) in the Era of high-efficacy treatments.
Journal: Multiple sclerosis and related disorders
Published: June 10, 2025
Access, satisfaction, adherence and safety to subcutaneous natalizumab compared to intravenous natalizumab in multiple sclerosis in a real-life cohort: first report from Latin America.
Journal: Therapeutic advances in neurological disorders
Published: April 01, 2025
Cladribine use trend in Latin America: the changes in patient profile impact in the drug effectiveness.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: January 29, 2024
Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodies.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: September 27, 2022
Evaluation of the use of high-efficacy treatments (HETs) in patients with relapsing-remitting multiple sclerosis in Argentina.
Journal: Multiple sclerosis and related disorders
Published: July 27, 2022
Evaluation of adherence to treatment in patients with multiple sclerosis from Latin America.
Journal: Multiple sclerosis and related disorders
Published: February 25, 2022
Correction to: Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM).
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: September 24, 2021
Usage trend of oral drugs for multiple sclerosis patients in Argentina.
Journal: Multiple sclerosis and related disorders
Published: October 30, 2020
Absence of latitudinal gradient in oligoclonal bands prevalence in Argentina.
Journal: Multiple sclerosis and related disorders
Published: September 22, 2020
Aggressive multiple sclerosis in Argentina: Data from the nationwide registry RelevarEM.
Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Published: June 09, 2020
Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM).
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: May 23, 2020
Last Updated: 09/26/2026